148 related articles for article (PubMed ID: 28903317)
1. PD-L1 and c-MET expression and survival in patients with small cell lung cancer.
Miao L; Lu Y; Xu Y; Zhang G; Huang Z; Gong L; Fan Y
Oncotarget; 2017 Aug; 8(33):53978-53988. PubMed ID: 28903317
[TBL] [Abstract][Full Text] [Related]
2. Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer.
Ishii H; Azuma K; Kawahara A; Yamada K; Imamura Y; Tokito T; Kinoshita T; Kage M; Hoshino T
J Thorac Oncol; 2015 Mar; 10(3):426-30. PubMed ID: 25384063
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer.
Fu X; Liu Z; Xiang L; Liu M; Zheng X; Wang J; Liu N; Gao H; Jiang A; Yang Y; Liang X; Ruan Z; Tian T; Yao Y
Cancer Manag Res; 2020; 12():10939-10948. PubMed ID: 33154673
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 expression as poor prognostic factor in patients with non-squamous non-small cell lung cancer.
Zhou C; Tang J; Sun H; Zheng X; Li Z; Sun T; Li J; Wang S; Zhou X; Sun H; Cheng Z; Zhang H; Ma H
Oncotarget; 2017 Aug; 8(35):58457-58468. PubMed ID: 28938570
[TBL] [Abstract][Full Text] [Related]
5. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of PD-L1 in Central and Peripheral and TTF1-Positive and -Negative Small-Cell Lung Cancer.
Yu S; Jia M; Li Y; Sun PL; Gao H
Front Med (Lausanne); 2020; 7():621838. PubMed ID: 33585516
[No Abstract] [Full Text] [Related]
7. Survival analysis with regard to PD-L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors.
Xu Y; Cui G; Jiang Z; Li N; Zhang X
Oncol Lett; 2019 Mar; 17(3):2960-2968. PubMed ID: 30854074
[TBL] [Abstract][Full Text] [Related]
8. High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer.
Jing W; Wang S; Ding X; Guo H; Li J; Wang H; Kong L; Yu J; Zhu H
Int J Clin Exp Pathol; 2018; 11(5):2675-2682. PubMed ID: 31938382
[TBL] [Abstract][Full Text] [Related]
9. Programmed death-ligand 1 positivity can predict improved survival and a lower risk of brain metastasis in patients with resectable small cell lung cancer.
Liu J; Lu Z; Wang W; Sun X
Oncol Lett; 2018 Aug; 16(2):2373-2381. PubMed ID: 30008941
[TBL] [Abstract][Full Text] [Related]
10. Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection.
Kwon MJ; Kim KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK; Kang HS; Min KW
Oncotarget; 2017 Oct; 8(47):82399-82414. PubMed ID: 29137273
[TBL] [Abstract][Full Text] [Related]
11. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
[TBL] [Abstract][Full Text] [Related]
12. Favorable Disease-free Survival Associated with Programmed Death Ligand 1 Expression in Patients with Surgically Resected Small-cell Lung Cancer.
Toyokawa G; Takada K; Haratake N; Takamori S; Akamine T; Katsura M; Fujishita T; Shoji F; Okamoto T; Oda Y; Maehara Y
Anticancer Res; 2016 Aug; 36(8):4329-36. PubMed ID: 27466552
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer.
Chang MH; Lee J; Han J; Park YH; Ahn JS; Park K; Ahn MJ
APMIS; 2009 Dec; 117(12):861-9. PubMed ID: 20078550
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of PD-L1 expression for non-small cell lung cancer patients: a meta-analysis.
Wang A; Wang HY; Liu Y; Zhao MC; Zhang HJ; Lu ZY; Fang YC; Chen XF; Liu GT
Eur J Surg Oncol; 2015 Apr; 41(4):450-6. PubMed ID: 25682184
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
Kim MY; Koh J; Kim S; Go H; Jeon YK; Chung DH
Lung Cancer; 2015 Apr; 88(1):24-33. PubMed ID: 25662388
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of integrin β1, E-cadherin, and rac1 expression in small cell lung cancer.
Chang MH; Lee K; Lee KY; Kim YS; Kim YK; Kang JH
APMIS; 2012 Jan; 120(1):28-38. PubMed ID: 22151306
[TBL] [Abstract][Full Text] [Related]
17. Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer.
Igawa S; Sato Y; Ryuge S; Ichinoe M; Katono K; Hiyoshi Y; Otani S; Nagashio R; Nakashima H; Katagiri M; Sasaki J; Murakumo Y; Satoh Y; Masuda N
Oncology; 2017; 92(5):283-290. PubMed ID: 28222447
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
Wang X; Jiang R; Li K
Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.
Cooper WA; Tran T; Vilain RE; Madore J; Selinger CI; Kohonen-Corish M; Yip P; Yu B; O'Toole SA; McCaughan BC; Yearley JH; Horvath LG; Kao S; Boyer M; Scolyer RA
Lung Cancer; 2015 Aug; 89(2):181-8. PubMed ID: 26024796
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.
Lee SY; Jung DK; Choi JE; Jin CC; Hong MJ; Do SK; Kang HG; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
Gene; 2017 Jan; 599():28-35. PubMed ID: 27838455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
